Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta

NCT01417091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

DRUG: BPS804

Sponsor

Ultragenyx Pharmaceutical Inc